Showing 4,901 - 4,920 results of 12,750 for search '"therapeutics"', query time: 0.09s Refine Results
  1. 4901
  2. 4902

    CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis by M. Eugenia Delgado, Salvador Naranjo-Suarez, Marta Ramírez-Pedraza, Beatriz I. Cárdenas, Carmen Gallardo-Martínez, Alexandra Balvey, Eulalia Belloc, Judit Martín, Mark Boyle, Raúl Méndez, Mercedes Fernandez

    Published 2025-03-01
    “…Background & Aims: Liver cancer is a significant global health issue, with its incidence rising in parallel with the obesity epidemic. The limited therapeutic options available emphasize the need for a better understanding of the molecular pathways involved in its pathogenesis. …”
    Get full text
    Article
  3. 4903

    Impact of donor CYP3A5 genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients by C Wheeler, C Masimirembwa, B Mthembu, J Botha, J Scholefield, J Fabian

    Published 2024-04-01
    “…It is characterised by a narrow therapeutic index and wide interpatient variability, necessitating therapeutic drug monitoring of whole-blood concentrations. …”
    Get full text
    Article
  4. 4904

    miR124a-3p inhibitor alleviates AFB1-induced hepatoxicity via targeting chicken glucocorticoid receptor mRNA by Mindie Zhao, Liang Chen, Yulan Zhao, Jie Liu, Huimin Chen, Ruqian Zhao

    Published 2025-03-01
    “…This study highlights GR and its miRNA as potential therapeutic targets for AFB1-induced liver disease, providing new insights into therapeutic strategies to mitigate the harmful effects of AFB1 exposure in poultry.…”
    Get full text
    Article
  5. 4905

    Chaihu Shugan San and Zuogui Yin synergistically improve premature ovarian failure in a rat model via the PI3K/Akt/mTOR pathway by Fei Zhang, RuiFang Liu, ZhenLing Xu, WenJie Chen, XiYa Lu, Yang Wang

    Published 2025-03-01
    “…This study aims to evaluate the therapeutic effects of Chaihu Shugan San, Zuogui Yin, and their combination on POI in a rat model and to elucidate the underlying mechanisms involving the PI3K/Akt/mTOR signaling pathway. …”
    Get full text
    Article
  6. 4906
  7. 4907

    RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melan... by Sara Egea‐Rodriguez, Renáta Váraljai, Thierry M. Nordmann, Restuan Lubis, Manuel Philip, Florian Rambow, Alexander Roesch, Michael Flaig, Susanne Horn, Raphael Stoll, Fang Zhao, Annette Paschen, Bert Klebl, Ian D. Hickson, Dirk Schadendorf, Matthias Mann, Iris Helfrich

    Published 2025-01-01
    “…Abstract Background Cancer immunotherapy has transformed metastatic cancer treatment, yet challenges persist regarding therapeutic efficacy. RECQL4, a RecQ‐like helicase, plays a central role in DNA replication and repair as part of the DNA damage response, a pathway implicated in enhancing efficacy of immune checkpoint inhibitor (ICI) therapies. …”
    Get full text
    Article
  8. 4908

    Advances in the Treatment of Desseminated Mycobacterium avium Complex in Adults with AIDS by Carol A Kemper

    Published 1994-01-01
    “…Though our understanding of this infection has been rapidly advanced in the past three years. much remains to be learned about its optimal therapeutic management.…”
    Get full text
    Article
  9. 4909
  10. 4910

    Radiologic Evaluation of Small Renal Masses (II): Posttreatment Management by J. Santos, C. Deltoro, M. I. Martín, A. Marhuenda

    Published 2008-01-01
    “…The increase in the detection of small renal masses (SRMs) and their best knowledge leads to a change in the therapeutic management of these lesions. The use of a less aggressive surgical technique or even an expectant attitude is the current tendency, in order to preserve as much renal function as possible. …”
    Get full text
    Article
  11. 4911

    Manipulation of the Complement System for Benefit in Sepsis by Peter A. Ward, Ren-Feng Guo, Niels C. Riedemann

    Published 2012-01-01
    “…Based on these data, it seems reasonable to consider therapeutic blockade of C5a in humans entering into sepsis and septic shock. …”
    Get full text
    Article
  12. 4912

    Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation by Takashige Kiyota, Seiji Shiota, Ryosuke Hamanaka, Daisuke Tsutsumi, Takeshi Takakura, Eishi Miyazaki

    Published 2019-01-01
    “…Rifampicin suppresses the anticoagulant activity of warfarin, which can lead to a need for increased doses of warfarin to achieve and maintain a therapeutic INR. More frequent INR monitoring is needed even after discontinuing rifampicin.…”
    Get full text
    Article
  13. 4913

    The Off-Label Use of a Lumen-Apposing Metal Stent (LAMS) for a Benign Colon Anastomotic Stricture Causing Recurrent Bowel Obstruction in a Patient with Keloids by Michael Coles, Pearl Uy, Victoria Madray, John Erikson Yap, Subbaramiah Sridhar

    Published 2021-01-01
    “…Lumen-apposing metal stents (LAMSs) have recently emerged as a potentially superior therapeutic option. We herein report a patient with a past medical history of pT3, N0 adenocarcinoma of the colon with anastomotic stricture recurrence who underwent successful placement of an LAMS. …”
    Get full text
    Article
  14. 4914

    Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review by Nikolaos Dervenis, Eleftherios Agorogiannis, Panagiotis Dervenis

    Published 2024-05-01
    “…At the same time, new challenges and unmet needs arose due to the limitations of the current therapeutic options. Neovascularisation development during the course of the disease has a complex pathogenetic mechanism, and several biomarkers and their association with treatment outcomes have been investigated. …”
    Get full text
    Article
  15. 4915

    Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases by Qiaolin Huang, Xiaojian Zhu, Yicheng Zhang

    Published 2025-02-01
    “…However, realizing broader therapeutic applications of engineered T cells in other diseases requires further exploration in clinical investigations. …”
    Get full text
    Article
  16. 4916

    The molecular mechanisms of cuproptosis and its relevance to atherosclerosis by Jiankang Wang, Zhian Chen, Hang Shang, Jiajuan Guo

    Published 2025-01-01
    “…The goal is to propose novel diagnostic and therapeutic strategies for atherosclerosis through the lens of cuproptosis.  …”
    Get full text
    Article
  17. 4917

    A Case of Transcatheter Aortic Valve Implantation in a Centenarian Patient by Salem Badr, Daniel O. Johnsrud, Charnai D. Sherry, Suhail Q. Allaqaband, Eric S. Weiss, Tanvir K. Bajwa

    Published 2021-01-01
    “…In recent years, transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic option for severe aortic stenosis. However, there is a paucity of data regarding the outcomes of TAVI in patients older than 100 years. …”
    Get full text
    Article
  18. 4918

    From Inflammation to Current and Alternative Therapies Involved in Wound Healing by Mariana Barreto Serra, Wermerson Assunção Barroso, Neemias Neves da Silva, Selma do Nascimento Silva, Antonio Carlos Romão Borges, Iracelle Carvalho Abreu, Marilene Oliveira da Rocha Borges

    Published 2017-01-01
    “…Finally, we will discuss the current therapeutic interventions in the wounds treatment, and the alternative therapies used as promising results in the development of new products with healing potential.…”
    Get full text
    Article
  19. 4919

    Postmenopausal Deep Infiltrating Endometriosis of the Colon: Rare Location and Novel Medical Therapy by Benjamin M. Snyder, Joseph W. Beets, Bruce A. Lessey, Samuel R. W. Horton, Gary A. Abrams

    Published 2018-01-01
    “…Instead of surgery, we prescribed a novel medical therapeutic approach using conjugated estrogen-bazedoxifene to antagonize the proliferative effects of estrogen on endometrial tissue. …”
    Get full text
    Article
  20. 4920

    Fecal microbiota transplantation: lights and shadows of a new weapon against inflammatory bowel disease by Andrea Piccioni, Federico Rosa, Federica Manca, Davide Antonio Della Polla, Martina Petrucci, Benedetta Simeoni, Marcello Covino

    Published 2023-03-01
    “…For this reason, similar to what happened for Clostridium difficile, fecal microbiota transplantation is making its way as a possible new therapeutic weapon in the treatment of this disease. …”
    Get full text
    Article